Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
about
Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infectionRecent advances in Brucella abortus vaccinesProtective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis.Cloning, expression, and characterization of TonB2 from Actinobacillus pleuropneumoniae and potential use as an antigenic vaccine candidate and diagnostic marker.Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51Meta-Analysis and Advancement of Brucellosis Vaccinology.A history of the development of Brucella vaccines.Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infectionTechnical transformation of biodefense vaccines.Confronting the barriers to develop novel vaccines against brucellosis.Hepatitis B immunopathogenesis and immunotherapy.In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate.Immunogenicity Analysis of a Novel Subunit Vaccine Candidate Molecule-Recombinant L7/L12 Ribosomal Protein of Brucella suis.Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice.In silico design, cloning and high level expression of L7/L12-TOmp31 fusion protein of Brucella antigens.Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.Multivalent Fusion DNA Vaccine against Brucella abortus.Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis.Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice.In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens.Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice.
P2860
Q28658422-0539E247-096E-457E-8AAF-1039B6106087Q34484123-8D868B72-C1B8-44BB-AB80-0B079A84C2EFQ34484164-98754B88-1589-468B-9D24-F4DB49DB8F3FQ34592993-0DBC995C-17DE-40D3-8682-CE3452129F42Q34743375-3AB83068-77F1-4A6C-AC81-DDD27163F302Q35067495-953C83D7-8F13-4231-ACE8-A0A2FEDCCEA2Q35122817-88F2468F-D247-4EEF-A7E3-43E42FD88E01Q35767656-8D3AF4A2-A755-4DC3-99DC-80160EEA4207Q36192841-C2C338A4-BCC1-4E13-80EB-8AD101736AD8Q36938722-8D21B837-0573-4842-AB73-12BEAFEAE5ABQ37033007-6CA101BC-9481-41D2-A997-A691C095D6B9Q37058898-74CF41A0-5C99-41C1-99C4-84D549AC6948Q37932521-AAA9A777-37B7-4F2A-84B0-DDC86661298CQ38773364-D9EDDC50-5DF1-4E11-8EC5-0FE4AA12CAB7Q39461733-1106B304-F7BB-4167-B606-DDAD33760864Q40716095-819E8210-2269-4A73-B4E5-8041DA1C6B3FQ41459448-F1491109-2DC6-4B79-A8BE-2627627F6FC8Q41938593-AD052F94-2CEB-4CD5-8E8C-4E8E762142B1Q42283292-5BCAF36E-B3E4-4A7F-A0D0-9E1933D3ACAFQ42730539-20A19C18-F56F-4FA8-83AF-C4305AC45A33Q42909254-1FB06176-AFEC-4111-8FCA-E49C392DEE63Q43177186-EECFDE5F-2AC8-447A-889E-7F46FD4C63B0Q46258488-24C59736-6EED-4FCF-94FA-7F1940BD85E1Q49378999-C27267C4-6DBF-4946-B8D2-44267CCBE08EQ52358100-F1653E82-CFFC-47CB-9EAB-0A13981014FCQ54332192-32EEA98C-2A31-4626-BF82-B755E94FC2E9
P2860
Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@ast
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@en
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@nl
type
label
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@ast
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@en
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@nl
prefLabel
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@ast
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@en
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@nl
P2093
P2860
P1476
Protective immunity elicited b ...... ucella abortus in BALB/c mice.
@en
P2093
Songle Zhang
Xiliang Wang
Yangdong He
Yuzhang Wu
P2860
P304
P356
10.1128/IAI.74.5.2734-2741.2006
P407
P577
2006-05-01T00:00:00Z